Angiotensin II Regulation of Proliferation, Differentiation, and Engraftment of Hematopoietic Stem Cells

Hypertension

Volumn 67, Issue 3, 2016, Pages 574-584

  Kim, Seungbum ^a   Zingler, Michael ^a   Harrison, Jeffrey K ^a   Scott, Edward W ^a   Cogle, Christopher R ^a   Luo, Defang ^a   Raizada, Mohan K ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

angiotensin II; bone marrow transplantation; hematopoietic stem cells; hypertension; inflammation

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; CHEMOKINE RECEPTOR CCR2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; MONOCYTE; MONONUCLEAR CELL; MOUSE; MYELOPOIESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SPLEEN CELL; ANIMAL; BAGG ALBINO MOUSE; CYTOLOGY; DISEASE MODEL; HEMATOPOIETIC STEM CELL; HYPERTENSION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; VIDEORECORDING;

ANGIOTENSIN II; ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HYPERTENSION; MALE; MICE; MICE, INBRED BALB C; VIDEO RECORDING;

EID: 84958040356     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.115.06474     Document Type: Article

References (59)

1. Zambidis ET, Park TS, Yu W, Tam A, Levine M, Yuan X, Pryzhkova M, Péault B. Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood. 2008; 112: 3601-3614. doi: 10.1182/blood-2008-03-144766.
2. Savary K, Michaud A, Favier J, Larger E, Corvol P, Gasc JM. Role of the renin-angiotensin system in primitive erythropoiesis in the chick embryo. Blood. 2005; 105: 103-110. doi: 10.1182/blood-2004-04-1570.
3. Sinka L, Biasch K, Khazaal I, Péault B, Tavian M. Angiotensin-converting enzyme (CD143) specifies emerging lympho-hematopoietic progenitors in the human embryo. Blood. 2012; 119: 3712-3723. doi: 10.1182/blood-2010-11-314781.
4. Jokubaitis VJ, Sinka L, Driessen R, Whitty G, Haylock DN, Bertoncello I, Smith I, Péault B, Tavian M, Simmons PJ. Angiotensin-converting enzyme (CD143) marks hematopoietic stem cells in human embryonic, fetal, and adult hematopoietic tissues. Blood. 2008; 111: 4055-4063. doi: 10.1182/blood-2007-05-091710.
5. Park TS, Zambidis ET. A role for the renin-angiotensin system in hematopoiesis. Haematologica. 2009; 94: 745-747. doi: 10.3324/haematol.2009.006965.
6. Hubert C, Savary K, Gasc JM, Corvol P. The hematopoietic system: a new niche for the renin-angiotensin system. Nat Clin Pract Cardiovasc Med. 2006; 3: 80-85. doi: 10.1038/ncpcardio0449.
7. Rodgers KE, Dizerega GS. Contribution of the local RAS to hematopoietic function: a novel therapeutic target. Front Endocrinol (Lausanne). 2013; 4: 157. doi: 10.3389/fendo.2013.00157.
8. Haznedaroglu IC, Oztürk MA. Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. Int J Biochem Cell Biol. 2003; 35: 867-880.
9. Strawn WB, Richmond RS, Ann Tallant E, Gallagher PE, Ferrario CM. Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells. Br J Haematol. 2004; 126: 120-126. doi: 10.1111/j.1365-2141.2004.04998.x.
10. Chisi JE, Wdzieczak-Bakala J, Thierry J, Briscoe CV, Riches AC. Captopril inhibits the proliferation of hematopoietic stem and progenitor cells in murine long-term bone marrow cultures. Stem Cells. 1999; 17: 339-344. doi: 10.1002/stem.170339.
11. Rodgers K, Xiong S, DiZerega GS. Effect of angiotensin II and angiotensin( 1-7) on hematopoietic recovery after intravenous chemotherapy. Cancer Chemother Pharmacol. 2003; 51: 97-106. doi: 10.1007/s00280-002-0509-4.
12. Rodgers KE, Xiong S, diZerega GS. Accelerated recovery from irradiation injury by angiotensin peptides. Cancer Chemother Pharmacol. 2002; 49: 403-411. doi: 10.1007/s00280-002-0434-6.
13. Jun JY, Zubcevic J, Qi Y, Afzal A, Carvajal JM, Thinschmidt JS, Grant MB, Mocco J, Raizada MK. Brain-mediated dysregulation of the bone marrow activity in angiotensin II-induced hypertension. Hypertension. 2012; 60: 1316-1323. doi: 10.1161/HYPERTENSIONAHA.112.199547.
14. Santisteban MM, Ahmari N, Carvajal JM, Zingler MB, Qi Y, Kim S, Joseph J, Garcia-Pereira F, Johnson RD, Shenoy V, Raizada MK, Zubcevic J. Involvement of bone marrow cells and neuroinflammation in hypertension. Circ Res. 2015; 117: 178-191. doi: 10.1161/CIRCRESAHA.117.305853.
15. Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR, Vinh A, Weyand CM. Inflammation, immunity, and hypertension. Hypertension. 2011; 57: 132-140. doi: 10.1161/HYPERTENSIONAHA.110.163576.
16. Trott DW, Harrison DG. The immune system in hypertension. Adv Physiol Educ. 2014; 38: 20-24. doi: 10.1152/advan.00063.2013.
17. Wenzel P, Knorr M, Kossmann S, et al. Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction. Circulation. 2011; 124: 1370-1381. doi: 10.1161/CIRCULATIONAHA.111.034470.
18. Nahrendorf M, Pittet MJ, Swirski FK. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation. 2010; 121: 2437-2445. doi: 10.1161/CIRCULATIONAHA.109.916346.
19. Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science. 2013; 339: 161-166. doi: 10.1126/science.1230719.
20. Pasquini MC, Aljurf MD, Confer DL, et al. Global hematopoietic stem cell transplantation (HSCT) at one million: an achievement of pioneers and foreseeable challenges for the next decade. A report from the worldwide network for blood and marrow transplantation (WBMT). Blood. 2013; 122: 2133-2133.
21. Chinen J, Buckley RH. Transplantation immunology: solid organ and bone marrow. J Allergy Clin Immunol. 2010; 125(2 suppl 2): S324-S335. doi: 10.1016/j.jaci.2009.11.014.
22. Lassila M. Interaction of cyclosporine A and the renin-angiotensin system; new perspectives. Curr Drug Metab. 2002; 3: 61-71.
23. Nishiyama A, Kobori H, Fukui T, Zhang GX, Yao L, Rahman M, Hitomi H, Kiyomoto H, Shokoji T, Kimura S, Kohno M, Abe Y. Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension. Hypertension. 2003; 42: 754-760. doi: 10.1161/01. HYP.0000085195.38870.44.
24. Curtis JJ. Hypertensinogenic mechanism of the calcineurin inhibitors. Curr Hypertens Rep. 2002; 4: 377-380.
25. Nilsson SK, Simmons PJ, Bertoncello I. Hemopoietic stem cell engraftment. Exp Hematol. 2006; 34: 123-129. doi: 10.1016/j. exphem.2005.08.006.
26. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood. 2005; 106: 1901-1910. doi: 10.1182/blood-2005-04-1417.
27. Purton LE, ScVdden DT. The hematopoietic stem cell niche. In: StemBook [Internet]. Cambridge, MA: Harvard Stem Cell Institute; 2008.
28. Arai F, Suda T. Quiescent stem cells in the niche. StemBook [Internet]. Cambridge, MA: Harvard Stem Cell Institute; 2008.
29. Purton LE, Scadden DT. Limiting factors in murine hematopoietic stem cell assays. Cell Stem Cell. 2007; 1: 263-270. doi: 10.1016/j. stem.2007.08.016.
30. Dutta P, Sager HB, Stengel KR, et al. Myocardial Infarction Activates CCR2(+) hematopoietic stem and progenitor cells. Cell Stem Cell. 2015; 16: 477-487. doi: 10.1016/j.stem.2015.04.008.
31. Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, Weisberg SP, Mack M, Charo IF. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest. 2007; 117: 902-909. doi: 10.1172/JCI29919.
32. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, Figueiredo JL, Kohler RH, Chudnovskiy A, Waterman P, Aikawa E, Mempel TR, Libby P, Weissleder R, Pittet MJ. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009; 325: 612-616. doi: 10.1126/science.1175202.
33. Bengtsson NE, Kim S, Lin L, Walter GA, Scott EW. Ultra-high-field MRI real-time imaging of HSC engraftment of the bone marrow niche. Leukemia. 2011; 25: 1223-1231. doi: 10.1038/leu.2011.72.
34. Yin T, Li L. The stem cell niches in bone. J Clin Invest. 2006; 116: 1195-1201. doi: 10.1172/JCI28568.
35. Kunisaki Y, Bruns I, Scheiermann C, Ahmed J, Pinho S, Zhang D, Mizoguchi T, Wei Q, Lucas D, Ito K, Mar JC, Bergman A, Frenette PS. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature. 2013; 502: 637-643. doi: 10.1038/nature12612.
36. Wilson A, Laurenti E, Oser G, van der Wath RC, Blanco-Bose W, Jaworski M, Offner S, Dunant CF, Eshkind L, Bockamp E, Lió P, Macdonald HR, Trumpp A. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell. 2008; 135: 1118-1129. doi: 10.1016/j.cell.2008.10.048.
37. Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol. 2007; 292: C82-C97. doi: 10.1152/ajpcell.00287.2006.
38. Rodgers KE, Xiong S, Steer R, diZerega GS. Effect of angiotensin II on hematopoietic progenitor cell proliferation. Stem Cells. 2000; 18: 287-294. doi: 10.1634/stemcells.18-4-287.
39. Lin C, Datta V, Okwan-Duodu D, Chen X, Fuchs S, Alsabeh R, Billet S, Bernstein KE, Shen XZ. Angiotensin-converting enzyme is required for normal myelopoiesis. FASEB J. 2011; 25: 1145-1155. doi: 10.1096/fj.10-169433.
40. Tsubakimoto Y, Yamada H, Yokoi H, et al. Bone marrow angiotensin AT1 receptor regulates differentiation of monocyte lineage progenitors from hematopoietic stem cells. Arterioscler Thromb Vasc Biol. 2009; 29: 1529-1536. doi: 10.1161/ATVBAHA.109.187732.
41. Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 2003; 425: 841-846. doi: 10.1038/nature02040.
42. Querques F, Cantilena B, Cozzolino C, Esposito MT, Passaro F, Parisi S, Lombardo B, Russo T, Pastore L. Angiotensin receptor I stimulates osteoprogenitor proliferation through TGFβ-mediated signaling. J Cell Physiol. 2015; 230: 1466-1474. doi: 10.1002/jcp.24887.
43. Méndez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A, Enikolopov GN, Frenette PS. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature. 2010; 466: 829-834. doi: 10.1038/nature09262.
44. Zhang Y, Lv J, Guo H, Wei X, Li W, Xu Z. Hypoxia-induced proliferation in mesenchymal stem cells and angiotensin II-mediated PI3K/AKT pathway. Cell Biochem Funct. 2015; 33: 51-58. doi: 10.1002/cbf.3080.
45. Diop-Frimpong B, Chauhan VP, Krane S, Boucher Y, Jain RK. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors. Proc Natl Acad Sci U S A. 2011; 108: 2909-2914. doi: 10.1073/pnas.1018892108.
46. Lam BS, Cunningham C, Adams GB. Pharmacologic modulation of the calcium-sensing receptor enhances hematopoietic stem cell lodgment in the adult bone marrow. Blood. 2011; 117: 1167-1175. doi: 10.1182/blood-2010-05-286294.
47. Morita Y, Iseki A, Okamura S, Suzuki S, Nakauchi H, Ema H. Functional characterization of hematopoietic stem cells in the spleen. Exp Hematol. 2011; 39: 351-359.e3. doi: 10.1016/j.exphem.2010.12.008.
48. Griseri T, McKenzie BS, Schiering C, Powrie F. Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation. Immunity. 2012; 37: 1116-1129. doi: 10.1016/j.immuni.2012.08.025.
49. Massberg S, Schaerli P, Knezevic-Maramica I, Köllnberger M, Tubo N, Moseman EA, Huff IV, Junt T, Wagers AJ, Mazo IB, von Andrian UH. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell. 2007; 131: 994-1008. doi: 10.1016/j.cell.2007.09.047.
50. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells. 1978; 4: 7-25.
51. Ishibashi M, Hiasa K, Zhao Q, Inoue S, Ohtani K, Kitamoto S, Tsuchihashi M, Sugaya T, Charo IF, Kura S, Tsuzuki T, Ishibashi T, Takeshita A, Egashira K. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Circ Res. 2004; 94: 1203-1210. doi: 10.1161/01. RES.0000126924.23467.A3.
52. Wang G, O K. Homocysteine stimulates the expression of monocyte chemoattractant protein-1 receptor (CCR2) in human monocytes: possible involvement of oxygen free radicals. Biochem J. 2001; 357(pt 1): 233-240.
53. Libby P. Inflammation and cardiovascular disease mechanisms. Am J Clin Nutr. 2006; 83: 456S-460S.
54. Shan Z, Zubcevic J, Shi P, Jun JY, Dong Y, Murą TM, Lamont GJ, Cuadra A, Yuan W, Qi Y, Li Q, Paton JF, Katovich MJ, Sumners C, Raizada MK. Chronic knockdown of the nucleus of the solitary tract AT1 receptors increases blood inflammatory-endothelial progenitor cell ratio and exacerbates hypertension in the spontaneously hypertensive rat. Hypertension. 2013; 61: 1328-1333. doi: 10.1161/HYPERTENSIONAHA.111.00156.
55. Zubcevic J, Jun JY, Kim S, Perez PD, Afzal A, Shan Z, Li W, Santisteban MM, Yuan W, Febo M, Mocco J, Feng Y, Scott E, Baekey DM, Raizada MK. Altered inflammatory response is associated with an impaired autonomic input to the bone marrow in the spontaneously hypertensive rat. Hypertension. 2014; 63: 542-550. doi: 10.1161/HYPERTENSIONAHA.113.02722.
56. Zubcevic J, Santisteban MM, Pitts T, Baekey DM, Perez PD, Bolser DC, Febo M, Raizada MK. Functional neural-bone marrow pathways: implications in hypertension and cardiovascular disease. Hypertension. 2014; 63: e129-e139. doi: 10.1161/HYPERTENSIONAHA.114.02440.
57. Catt KJ, Cain MD, Zimmet PZ, Cran E. Blood angiotensin II levels of normal and hypertensive subjects. Br Med J. 1969; 1: 819-821.
58. Savani BN, Griffith ML, Jagasia S, Lee SJ. How I treat late effects in adults after allogeneic stem cell transplantation. Blood. 2011; 117: 3002-3009. doi: 10.1182/blood-2010-10-263095.
59. Chisi JE, Briscoe CV, Ezan E, Genet R, Riches AC, Wdzieczak-Bakala J. Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation. Br J Haematol. 2000; 109: 563-570.